Ovid Therapeutics Inc (OVID):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Ovid Therapeutics Inc (OVID) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C8142)・商品コード:DATA904C8142
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:45
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Ovid Therapeutics Inc (Ovid Therapeutics) is a bio-pharmaceutical company which identifies, discovers, and develops medicines for neurological disorders. The company’s pipeline products are indicated for diseases such as Angelman Syndrome and Fragile X Syndrome. It develops, assess, commercialize compounds and expand its product pipeline through research and development, acquisitions and combination therapies. Ovid Therapeutics works in partnership with patients, clinicians and scientists, foundations, academic centers, regulatory agencies, and companies that help the development of novel therapies. The company has collaboration with Lundbeck and Angelman Syndrome foundations. Ovid Therapeutics is headquartered in New York, the US.

Ovid Therapeutics Inc (OVID) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ovid Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Ovid Therapeutics Raises USD25.8 Million in Venture Financing 11
Partnerships 12
Ovid Therapeutics and NeuroPointDX Enter into Agreement 12
Takeda Pharma and Ovid Therapeutics Enter into Agreement 13
Licensing Agreements 15
Ovid Therapeutics Enters into Licensing Agreement with Northwestern University 15
Lundbeck Enters into Licensing Agreement with Ovid Therapeutics for Gaboxadol 17
Equity Offering 18
Ovid Therapeutics Plans to Raise up to USD200 Million in Public Offering of Securities 18
Ovid Therapeutics Raises USD75 Million in IPO 19
Ovid Therapeutics Raises Funds through Private Placement 21
Ovid Therapeutics Raises USD1 Million in Second Tranche of Private Placement of Shares 23
Ovid Therapeutics Raises USD4 Million in First Tranche of Private Placement of Shares 24
Ovid Therapeutics Inc – Key Competitors 25
Ovid Therapeutics Inc – Key Employees 26
Ovid Therapeutics Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Aug 09, 2018: Ovid Therapeutics reports second quarter 2018 financial results and highlights recent clinical progress 28
May 08, 2018: Ovid Therapeutics Reports First Quarter 2018 Financial Results and Corporate Progress 31
Mar 29, 2018: Ovid Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Progress 34
Nov 09, 2017: Ovid Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Progress 36
Aug 10, 2017: Ovid Therapeutics Reports Second Quarter 2017 Financial Results and Corporate Progress 38
Jun 13, 2017: Ovid Therapeutics Reports First Quarter 2017 Financial Results and Recent Corporate Progress 40
Corporate Communications 42
Sep 04, 2018: Dr. Yaron Werber, Chief Business and Financial Officer of Ovid Therapeutics, to Return to Wall Street 42
Jun 23, 2017: Ovid Therapeutics to be Added to Russell 2000, 3000 and Microcap Indexes 43
Jun 14, 2017: Ovid Therapeutics Appoints Barbara G. Duncan to its Board of Directors 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ovid Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Ovid Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ovid Therapeutics Raises USD25.8 Million in Venture Financing 11
Ovid Therapeutics and NeuroPointDX Enter into Agreement 12
Takeda Pharma and Ovid Therapeutics Enter into Agreement 13
Ovid Therapeutics Enters into Licensing Agreement with Northwestern University 15
Lundbeck Enters into Licensing Agreement with Ovid Therapeutics for Gaboxadol 17
Ovid Therapeutics Plans to Raise up to USD200 Million in Public Offering of Securities 18
Ovid Therapeutics Raises USD75 Million in IPO 19
Ovid Therapeutics Raises Funds through Private Placement 21
Ovid Therapeutics Raises USD1 Million in Second Tranche of Private Placement of Shares 23
Ovid Therapeutics Raises USD4 Million in First Tranche of Private Placement of Shares 24
Ovid Therapeutics Inc, Key Competitors 25
Ovid Therapeutics Inc, Key Employees 26
Ovid Therapeutics Inc, Other Locations 27

List of Figures
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ovid Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ovid Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[Ovid Therapeutics Inc (OVID):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C8142)販売に関する免責事項を必ずご確認ください。
★調査レポート[Ovid Therapeutics Inc (OVID):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆